Results 101 to 110 of about 6,337,399 (329)
Nail Toxicities Associated With Anticancer Therapies in Children
ABSTRACT Nail toxicities are a frequent yet often underrecognized component of dermatologic adverse events in children receiving anticancer therapies. Both conventional cytotoxic chemotherapy and newer targeted agents can affect the nail matrix, nail bed and periungual tissues, producing a broad spectrum of clinical manifestations that range from ...
Luca Rapparini, Michela Starace
wiley +1 more source
A case of levocetirizine-induced fixed drug eruption and cross-reaction with piperazine derivatives
Fixed drug eruption is an uncommon adverse drug reaction caused by delayed cell-mediated hypersensitivity. Levocetirizine is an active (R)-enatiomer of cetirizine and there have been a few reports of fixed drug eruption related to these antihistamines ...
Mi-Yeong Kim +5 more
semanticscholar +1 more source
Bullous fixed drug eruption to ciprofloxacin: a case report.
Adverse reactions to medications are extremely common and display a characteristic clinical morphology such as fixed drug eruption (FDE), Stevens-Johnson syndrome, urticaria, morbilliform exanthem, hypersensitivity syndrome, pigmentary changes, lichenoid,
Sonia Jain, P. Jain
semanticscholar +1 more source
Fixed drug eruption caused by tadalafil - Case report
Fixed drug eruptions (FDE) are commonly reported type of mucocutaneous drug eruption. The aim of this paper is to present a patient with multiple mucocutaneous erythema fixum type lesions caused by oral tadalafil use.
M. Bjekić +2 more
semanticscholar +1 more source
Doxycycline induced generalized bullous fixed drug eruption - A case report.
Adverse drug reactions are a major hazard of modern medicine. Fixed drug eruption, which is a cutaneous adverse drug reaction, is commonly seen with antimicrobials and analgesics. Here we report 37-year-old female with bullous fixed drug eruptions due to
S. Nitya +3 more
semanticscholar +1 more source
Galcanezumab-induced fixed drug eruption
Skylar Klager, SM +3 more
doaj +1 more source
ABSTRACT Biologics and Janus kinase (JAK) inhibitors have transformed the management of atopic dermatitis (AD), yet some patients experience early worsening of disease activity during treatment initiation. In clinical trials, these events are typically recorded as treatment‐emergent adverse events (TEAEs), most commonly coded as “atopic dermatitis”. We
Diego Ruiz Dasilva +17 more
wiley +1 more source
Recurrent fixed drug eruption caused by citiolone
Citiolone (N-acetylhomocysteinethiolactone) is a thiolicderived medication frequently used in Spain and in other countries as a mucolytic agent for the treatment of certain hepatic disorders. Mucolytic drugs have rarely been implicated in the fixed drug
Barrio, Manuel de +5 more
core +1 more source
A 52-year-old African American female presented with severe left thigh pain of unknown etiology. She had a past medical history of generalized seizure disorder treated with phenytoin for 7 years without incident.
Keaton S. Smetana +2 more
doaj +1 more source

